Rika Sakai

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Clinicopathological and transcriptomic profiles of 101 patients with diffuse large B-cell lymphoma/high-grade B-cell lymphoma with double-hit MYC and BCL2 or BCL6 and triple hit.

Clinicopathological and transcriptomic profiles of 101 patients with diffuse large B-cell lymphoma/high-grade B-cell lymphoma with double-hit MYC and BCL2 or BCL6 and triple hit.

Journal: Histopathology

Published: October 02, 2025

Exploring leadership and promoting career development for female physicians

Exploring leadership and promoting career development for female physicians

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 03, 2025

Poor outcome of older patients with diffuse large B-cell lymphoma after progression.

Poor outcome of older patients with diffuse large B-cell lymphoma after progression.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 30, 2025

Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.

Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: March 16, 2025

Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.

Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: October 27, 2024

Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.

Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.

Journal: Leukemia

Published: October 04, 2024

Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL.

Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL.

Journal: International journal of hematology

Published: August 23, 2024

Survey of healthcare professionals' awareness of appearance care for Japanese cancer patients and their institutions' appearance care systems: report from the Japan Society of Clinical Oncology.

Survey of healthcare professionals' awareness of appearance care for Japanese cancer patients and their institutions' appearance care systems: report from the Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: June 27, 2024

Chemokine Expression in Well-Differentiated Liposarcoma May Be Involved in the Tumorigenesis of Lymphoplasmacytic Lymphoma: A Case Study.

Chemokine Expression in Well-Differentiated Liposarcoma May Be Involved in the Tumorigenesis of Lymphoplasmacytic Lymphoma: A Case Study.

Journal: Cancer reports (Hoboken, N.J.)

Published: June 12, 2024

Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.

Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 10, 2024

Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.

Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.

Journal: International journal of hematology

Published: March 27, 2024

SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

Journal: International cancer conference journal

Published: February 26, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026